Establishment Labs Holdings (ESTA) Short-Term Debt repayments (2026)
Establishment Labs Holdings' quarterly Short-Term Debt repayments came in at $1.2 million in Q1 2026.
Establishment Labs Holdings has reported Short-Term Debt repayments for 1 years, with the latest figure at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Short-Term Debt repayments changed N/A year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (changed N/A YoY), and the FY2025 full-year result was $1.0 million, changed N/A from the prior year.
- Short-Term Debt repayments for Q1 2026 stood at $1.2 million.
- The five-year high for Short-Term Debt repayments was $1.2 million in Q1 2026, with the low at $1.2 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 259.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Mn |
| Mar 31, 2026 | 1.17 Mn |